Vectors derived from baculovirus and use for transferring nucleic acids into nerve cells of vertebrates
US7018628B1 · kind B1 · utility
13Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 23, 1999 |
| Grant date | Mar 28, 2006 |
| Priority date | — |
| Expiry date | Jul 23, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/14143
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns novel recombinant viruses and their use for gene-transfer into nerve cells of vertebrates. The invention also concerns pharmaceutical compositions comprising said recombinant viruses. More particularly, the invention concerns novel vectors derived from baculoviruses and their use for treating diseases of the nervous system of vertebrates.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.